妇科领域的合作与授权协议（2016-2026）

妇科领域交易的明确指标

该妇科领域的合作关係涵盖了与女性健康相关的广泛适应症，其交易结构反映了创新、生命週期管理和专业商业策略的结合。

本报告对妇科领域的 157 项合作与许可协议进行了全面系统的分析，清楚地展示了伙伴关係在整个市场中的设计、谈判和执行方式，并提供了实证支持。

充分了解市场标准。

本报告将使您准确了解妇科领域交易的实际结构，使您能够：

• 自信地对标类似交易
• 对相关交易中的预付款、里程碑付款和特许权使用费结构进行详细分析。
• 设定切合实际的市场参数
• 您可以深入了解交易条款如何因阶段、资产类型和合作伙伴情况而异。
• 支持实证评估和结构性决策
• 我们将根据实际交易数据进行内部讨论，而不是根据假设。
• 了解主要企业如何进行交易。
• 在日益专业化和不断发展的女性医疗保健领域，可视化合作伙伴的行为和重复交易模式。
• 全面了解交易结构和执行情况
• 本报告超越了表面的交易数据，提供了对底层合约文件的访问，使您能够详细了解实际合约是如何构建的。

这包括：

• 授予和保留的权利
• 负责开发和商业化
• 财务结构和支付触发机制
• 关键合约条款和保障措施
• 这种程度的透明度对于了解妇科伙伴关係中价值、风险和控制权的分配方式至关重要，尤其是在受独特临床路径和商业性因素影响的领域。
• 它旨在用于实际的业务拓展和策略制定。

本报告主要广泛用于以下用途：

• 建置和基准测试实际交易
• 在清晰的市场环境下准备谈判
• 合作机会及目的地评估
• 支援稳健且引人注目的数据驱动型内部策略
• 内容
• 妇科领域共有157项合作与授权协议
• 财务条款，包括预付款、里程碑付款和版税（如有揭露）。
• 可全文搜寻的交易目录（依公司、治疗领域及技术分类）。
• 可直接查阅向美国证券交易委员会提交的合约和原始文件。
• 交易趋势分析、关键交易和活跃负责人
• 关于妇科领域交易的可靠、基于证据的参考资料。
• 本报告结合全面的交易报告和合约层面的深入分析，为如何在妇科领域建立、谈判和评估合作伙伴关係提供了可靠的、基于证据的参考资料。

目录

执行摘要

第一章：引言

第二章：妇科医疗保健交易趋势

• 介绍
• 在妇科领域长期合作
• 妇科领域的合作关係（依交易类型划分）
• 妇科领域的合作（依妇科专科划分）
• 妇科领域的合作（依发展阶段划分）
• 妇科领域的合作（依技术类型划分）
• 妇科领域的合作（依治疗适应症划分）

第三章 妇科合作中的财务交易条款

• 介绍
• 揭露妇科合作的财务条款。
• 妇科协作的关键价值
• 妇科治疗合约预付款
• 妇科相关合约的里程碑付款
• 与妇科相关的版税率

第四章：妇科领域的主要交易与相关人员

• 介绍
• 该公司在妇科领域积极寻求合作关係。
• 妇科领域业务最活跃的公司名单
• 妇科相关特价优惠（依价格排序）

第五章：妇科合约清单

• 介绍
• 与妇科相关的合伙协议（如有合约）

第六章 以治疗标靶的妇科药物研发

• 介绍
• 基于妇科治疗目标的交易
• 特价优惠列表
• 交易清单 - 妇科相关交易（依公司分类）AZ
• 交易清单 - 依技术类型分类的妇科相关交易清单。
• 交易类型的定义
• 关于这家研究公司
• Current Partnering
• 目前合约
• 理想合作伙伴最新报告的标题

The definitive benchmark for gynecology dealmaking

Gynecology partnering spans a range of indications within women's health, with deal structures reflecting a combination of innovation, lifecycle management, and specialized commercial strategies.

This report provides a comprehensive and structured analysis of 157 gynecology collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how gynecology deals are structured in practice, allowing you to:

• Benchmark comparable transactions with confidence
• Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
• Define realistic market parameters
• Clear insight into how deal terms vary by stage, asset type, and partner profile
• Support valuation and structuring decisions with evidence
• Ground internal discussions in real transaction data rather than assumptions
• Understand how leading companies approach dealmaking
• Visibility into partner behaviour and recurring deal structures across a specialized and evolving women's health landscape
• Full visibility into deal structure and execution
• Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

• Rights granted and retained
• Development and commercialization responsibilities
• Financial structures and payment triggers
• Key contractual provisions and protections
• This level of transparency is critical to understanding how value, risk, and control are allocated within gynecology partnerships, particularly in areas shaped by distinct clinical pathways and commercial considerations.
• Designed for real-world BD and strategy use

The report is widely used to:

• Structure and benchmark live transactions
• Prepare for negotiations with well-defined market context
• Evaluate partnership opportunities and counterparties
• Support internal strategy with robust, defensible data
• What's included
• 157 gynecology collaboration and licensing deals
• Financial terms, including upfronts, milestones, and royalties where disclosed
• Fully searchable deal directory (by company, therapy, and technology)
• Direct access to SEC-filed agreements and source documents
• Analysis of deal trends, key transactions, and active dealmakers
• A trusted, evidence-based reference for gynecology dealmaking
• Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how gynecology partnerships are structured, negotiated, and valued.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gynecology dealmaking

• 2.1. Introduction
• 2.2. Gynecology partnering over the years
• 2.3. Gynecology partnering by deal type
• 2.4. Gynecology partnering by industry sector
• 2.5. Gynecology partnering by stage of development
• 2.6. Gynecology partnering by technology type
• 2.7. Gynecology partnering by therapeutic indication

Chapter 3 - Financial deal terms for gynecology partnering

• 3.1. Introduction
• 3.2. Disclosed financials terms for gynecology partnering
• 3.3. Gynecology partnering headline values
• 3.4. Gynecology deal upfront payments
• 3.5. Gynecology deal milestone payments
• 3.6. Gynecology royalty rates

Chapter 4 - Leading gynecology deals and dealmakers

• 4.1. Introduction
• 4.2. Most active in gynecology partnering
• 4.3. List of most active dealmakers in gynecology
• 4.4. Top gynecology deals by value

Chapter 5 - Gynecology contract document directory

• 5.1. Introduction
• 5.2. Gynecology partnering deals where contract document available

Chapter 6 - Gynecology dealmaking by therapeutic target

• 6.1. Introduction
• 6.2. Deals by gynecology therapeutic target
• Deal directory
• Deal directory - Gynecology deals by company A-Z
• Deal directory - Gynecology deals by technology type
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Gynecology partnering since 2016
• Figure 2: Gynecology partnering by deal type since 2016
• Figure 3: Gynecology partnering by industry sector since 2016
• Figure 4: Gynecology partnering by stage of development since 2016
• Figure 5: Gynecology partnering by technology type since 2016
• Figure 6: Gynecology partnering by indication since 2016
• Figure 7: Gynecology deals with a headline value
• Figure 8: Gynecology deals with upfront payment values
• Figure 9: Gynecology deals with milestone payment
• Figure 10: Gynecology deals with royalty rates
• Figure 11: Active gynecology dealmaking activity since 2016
• Figure 12: Top gynecology deals by value since 2016